REF
9423
Description
Simultaneous detection and differentiation of 14 high-risk HPV genotypes
Packaging
96 test
Certification
The HPV-DNA test is important to prevent cervical cancer and it has been adopted as a screening test in women over the age of 30. The identification of the DNA of human papilloma virus (HPV) genotypes with a high oncogenic risk is crucial for positive PAP-tests and represents a fundamental follow-up tool as well.
Technology
Multiplexing technology
Target
Mastermix number
1
Internal control
Endogenous
UDG
Yes
Fluorophores
Limit of Detection (LoD)
~2-10 copies/rnx (depending on the genotype), see technical data sheet
Analytical specificity
A wide range of pathogens was used to test the assay. No cross-reactivity was found.
Diagnostic sensitivity
97,5 - 100%
Diagnostic specificity
99,8 - 100 %
Riproducibility
100 %
Specimen
Liquid-based cytology specimen
Validated thermalcyclers
CFX96 Real-Time PCR Detection System (Bio-Rad)
Software
NeoPlex Viewer/Easy-NAT
Fill out the form and send us your request.
Sarà nostra cura risponderti al più presto.
"*" indicates required fields